Mabwell Initiates Phase II Trial for Anti-IL-11 Antibody Targeting Pathological Scarring #China #Shanghai #Mabwell #Anti-IL-11 #Pathological_Scarring
1
0
0
0
Mabwell Initiates Phase II Trial for Anti-IL-11 Antibody Targeting Pathological Scarring #China #Shanghai #Mabwell #Anti-IL-11 #Pathological_Scarring